Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · IEX Real-Time Price · USD
0.250
+0.012 (5.18%)
Dec 8, 2023, 4:00 PM EST - Market closed
MTNB Stock Forecast
MTNB's stock price has decreased by -56.97% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for MTNB stock stock is $3.00, which predicts an increase of 1,101.92%. On average, analysts rate MTNB stock stock as a strong buy.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 11, 2023.
Analyst Ratings
The average analyst rating for MTNB stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +1,101.92% | Oct 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +1,101.92% | Jan 31, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 27, 2020 |
| SunTrust Robinson Humphrey | SunTrust Robinson Humphrey | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jan 24, 2020 |
| Maxim Group | Maxim Group | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Nov 13, 2018 |
Financial Forecast
Revenue This Year
1.12M
from 3.19M
Decreased by -64.87%
Revenue Next Year
n/a
from 1.12M
EPS This Year
-0.11
from -0.10
EPS Next Year
-0.12
from -0.11
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 1.2M | n/a | n/a | n/a | 29.7M | 77.0M |
| Avg | 1.1M | n/a | n/a | n/a | 28.8M | 74.8M |
| Low | 1.1M | n/a | n/a | n/a | 27.7M | 71.9M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -63.8% | - | - | - | - | 167.2% |
| Avg | -64.9% | - | - | - | - | 159.6% |
| Low | -66.3% | - | - | - | - | 149.4% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -0.12 | -0.13 | -0.11 | -0.09 | -0.02 | 0.11 |
| Avg | -0.11 | -0.12 | -0.10 | -0.09 | -0.02 | 0.10 |
| Low | -0.11 | -0.12 | -0.10 | -0.09 | -0.02 | 0.10 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | - |
| Avg | - | - | - | - | - | - |
| Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.